A Study of Pyrotinib Plus Capecitabine Combined With SRT in HER2+ MBC With Brain Metastases
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: HER2-positive Metastatic Breast Cancer
Interventions: COMBINATION_PRODUCT: radiation combined with pyrotinib and capecitabine
Sponsor: Jiangxi Provincial Cancer Hospital